References
- Adam P, Bonzheim I, Fend F, et al (2011). Epstein-Barr viruspositive diffuse large B-cell lymphomas of the elderly. Adv Anat Pathol, 18, 349-55. https://doi.org/10.1097/PAP.0b013e318229bf08
- Akhtar S, Haque S. I. u, Wafa S. M, et al (2009). Malignant lymphoma in Al-Qassim, Saudi Arabia, reclassified according to the WHO classification. Saudi Med J, 30, 677-81.
- Anagnostopoulos I, Hummel M, Finn T, et al (1992). Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood, 80, 1804-12.
- Wang Ao. Q. Y, Tian S. Xu. Y, Huang W, et al (2014). A case of EBV positive diffuse large B-cell lymphoma of the adolescent. Int J Clin Exp Med, 7, 307-11
- Silva Aw D. A. B, Palmer D. B (2007). Immunosenescence: emerging challenges for an ageing population. Immunol, 120, 435-46. https://doi.org/10.1111/j.1365-2567.2007.02555.x
- Barrionuevo C, Anderson V. M, Zevallos-Giampietri E, et al (2002). Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol, 10, 7-14.
- Beltran B. E, Castillo J. J, Morales D, et al (2011). EBV-positive diffuse large B-cell lymphoma of the elderly: A case series from Peru. Am J Hematol, 86, 663-67. https://doi.org/10.1002/ajh.22078
- Beltran B. E, Morales D, Quiñones P, et al (2011). EBV-positive diffuse large b-cell lymphoma in young immunocompetent individuals. Clin Lymphoma Myeloma Leuk, 11, 512-6. https://doi.org/10.1016/j.clml.2011.07.003
- Binesh F, Akhavan A, Behniafard N, et al (2013). Clinicopathologic and survival characteristics of childhood and adolescent non Hodgkin’s lymphoma in Yazd, Iran. Asian Pac J Cancer Prev, 15, 1585-8.
- Castillo J, Pantanowitz L, Dezube B. J (2008). HIV-associated plasmablastic lymphoma: Lessons learned from 112 published cases. Am J Hematol, 83, 804-9. https://doi.org/10.1002/ajh.21250
- Cohen J, Kimura H, Nakamura S, et al (2009). Epstein–Barr virus-associated lymphoproliferative disease in nonimmunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008. Ann Oncol, 20, 1472-82. https://doi.org/10.1093/annonc/mdp064
- Cohen M, Narbaitz M, Metrebian F, et al (2014). Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients. Int J Cancer, 135, 2816-24. https://doi.org/10.1002/ijc.28942
- Dojcinov S. D, Venkataraman G, Pittaluga S, et al (2011). Agerelated EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood, 117, 4726-35. https://doi.org/10.1182/blood-2010-12-323238
- Dunleavy K, Roschewski M, Wilson W. H (2012). Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep, 7, 208-15. https://doi.org/10.1007/s11899-012-0132-3
- Gibson S. E, Hsi E. D (2009). Epstein-Barr virus–positive B-cell lymphoma of the elderly at a United States tertiary medical center: an uncommon aggressive lymphoma with a nongerminal center B-cell phenotype. Hum Pathol, 40, 653-61. https://doi.org/10.1016/j.humpath.2008.10.007
- Hanif M, Zaidi P, Kamal S, et al (2009). Institution-based cancer incidence in a local population in Pakistan: nine year data analysis. Asian Pac J Cancer Prev, 10, 227-30.
- Hans C. P, Weisenburger D. D, Greiner T. C, et al (2004). Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood, 103, 275-82. https://doi.org/10.1182/blood-2003-05-1545
- Hecht J. L, Aster G.C (2000). Molecular biology of Burkitt’s lymphoma. J Clin Oncol, 18, 3707-21. https://doi.org/10.1200/JCO.2000.18.21.3707
- Hoeller S, Tzankov A, Pileri S.A, et al (2010). Epstein-Barr virus–positive diffuse large B-cell lymphoma in elderly patients is rare in Western populations. Hum Pathol, 41, 352-7. https://doi.org/10.1016/j.humpath.2009.07.024
- Hofscheier A, Ponciano A, Bonzheim I, et al (2011). Geographic variation in the prevalence of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a comparative analysis of a Mexican and a German population. Mod Pathol, 24, 1046-54. https://doi.org/10.1038/modpathol.2011.62
- Hong J, Yoon D, Suh C, et al (2015). EBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity? Ann Oncol, 26, 548-55. https://doi.org/10.1093/annonc/mdu556
- Hu S, Xu-Monette Z. Y, Tzankov A, et al (2013). MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. Blood, 121, 4021-31. https://doi.org/10.1182/blood-2012-10-460063
- Ishtiaq S, Hassan U, Mushtaq S, et al (2013). Determination of Frequency of Epstein-Barr Virus in Non-Hodgkin Lymphomas Using EBV Latent Membrane Protein 1 (EBVLMP1) Immunohistochemical Staining. Asian Pac J Cancer Prev, 14, 3963-7. https://doi.org/10.7314/APJCP.2013.14.6.3963
- Kanavaros P, Briere J, Emile J,et al (1996). Epstein-Barr virus in T and natural killer (NK) cell non-Hodgkin's lymphomas. Leukemia, 10, 84-87.
- Kilciksiz S, Pehlivan M, Yilmaz E, et al (2010). The clinical and pathological features of patients with hematological neoplasms: a study of hospital-based Cancer Registry from western Turkey. J BU ON, 16, 505-10.
- Kuze T, Nakamura N, Hashimoto Y, et al (2000). The characteristics of epstein-barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV+ and EBV-cases in Japanese population. Jpn J Cancer Res, 91, 1233-40. https://doi.org/10.1111/j.1349-7006.2000.tb00909.x
- Lu TX, Liang JH, Miao Y, et al (2015). Epstein-Barr virus positive diffuse large B-cell lymphoma predict poor outcome, regardless of the age. Sci Rep, 5, 12168. https://doi.org/10.1038/srep12168
- Morales D, Beltran B, De Mendoza F. H, et al (2010). Epstein- Barr virus as a prognostic factor in de novo nodal diffuse large B-cell lymphoma. Leuk Lymphoma, 51, 66-72. https://doi.org/10.3109/10428190903308015
- Morton L. M, Wang S. S, Devesa S. S, et al (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-76. https://doi.org/10.1182/blood-2005-06-2508
- Nakamura S, Jaffe E, Swerdlow S (2008). EBV positive diffuse large B-cell lymphoma of the elderly. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC, 243-44.
- Ok C. Y, Ye Q, Li L, et al (2015). Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma-is it necessary? Oncotarget, 6, 13933-46. https://doi.org/10.18632/oncotarget.4324
- Otrock Z. K, Saab J, Aftimos G, et al (2013). A collaborative nationwide lymphoma study in Lebanon: incidence of various subtypes and analysis of associations with viruses. Pathol Oncol Res, 19, 715-22. https://doi.org/10.1007/s12253-013-9634-0
- Oyama T, Yamamoto K, Asano N, et al (2007). Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res, 13, 5124-32. https://doi.org/10.1158/1078-0432.CCR-06-2823
- Park S, Lee J, Ko Y. H, et al (2007). The impact of Epstein- Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood, 110, 972-8. https://doi.org/10.1182/blood-2007-01-067769
- Quintanilla-Martinez L, de Jong D, de Mascarel A, et al (2009). Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France. J Hematopathol, 2, 211-36. https://doi.org/10.1007/s12308-009-0053-9
- Sabattini E, Bacci F, Sagramoso C, et al (2010). WHO classification of tumours of haematopoietic and lymphoid tissues in 2008: an overview. Pathologica, 102, 83-7.
- Shimoyama Y, Asano N, Kojima M, et al (2009). Agerelated EBV-associated B-cell lymphoproliferative disorders: Diagnostic approach to a newly recognized clinicopathological entity. Pathol Int, 59, 835-43. https://doi.org/10.1111/j.1440-1827.2009.02466.x
- Shimoyama Y, Yamamoto K, Asano N, et al (2008). Age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorders: Special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci, 99, 1085-91. https://doi.org/10.1111/j.1349-7006.2008.00813.x
- Uccini S, Al-Jadiry M. F, Scarpino S, et al (2015). Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly. Hum Pathol, 46, 716-24. https://doi.org/10.1016/j.humpath.2015.01.011
Cited by
- New developments in the pathology of malignant lymphoma: a review of the literature published from June–August 2016 vol.9, pp.3, 2016, https://doi.org/10.1007/s12308-016-0284-5
- Pediatric Pulmonary Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Case Report and Review of the Literature vol.2017, pp.2090-679X, 2017, https://doi.org/10.1155/2017/8946807